Your browser doesn't support javascript.
loading
ABCB1 polymorphisms predict imatinib response in chronic myeloid leukemia patients: a systematic review and meta-analysis.
Zheng, Q; Wu, H; Yu, Q; Kim, D H Dennis; Lipton, J H; Angelini, S; Soverini, S; Vivona, D; Takahashi, N; Cao, J.
Afiliación
  • Zheng Q; Clinical Research Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Wu H; Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Yu Q; Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Kim DH; Chronic Myelogenous Leukemia Group, Princess Margaret Cancer Centre, University Health Network University of Toronto, Toronto, Ontario, Canada.
  • Lipton JH; Chronic Myelogenous Leukemia Group, Princess Margaret Cancer Centre, University Health Network University of Toronto, Toronto, Ontario, Canada.
  • Angelini S; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
  • Soverini S; Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology, University of Bologna, Bologna, Italy.
  • Vivona D; Departmento de Análises Clínicas e Toxicológicas da Faculdade de Ciências Farmacêuticas da Universidade de São Paulo, São Paulo, Brazil.
  • Takahashi N; Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
  • Cao J; Clinical Research Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Pharmacogenomics J ; 15(2): 127-34, 2015 Apr.
Article en En | MEDLINE | ID: mdl-25245580

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Polimorfismo de Nucleótido Simple / Inhibidores de Proteínas Quinasas / Mesilato de Imatinib Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Humans / Middle aged Idioma: En Revista: Pharmacogenomics J Asunto de la revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Polimorfismo de Nucleótido Simple / Inhibidores de Proteínas Quinasas / Mesilato de Imatinib Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Humans / Middle aged Idioma: En Revista: Pharmacogenomics J Asunto de la revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: China